Oligonucleotide CDMO Market’s CAGR of 8.9%: Key Players
According to a newly published market research report by 24LifeSciences, global oligonucleotide process development and manufacturing market was valued at USD 1.14 billion in 2024 and is projected to reach USD 2.04 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025-2031.
Oligonucleotides, which are short, single-stranded DNA or RNA molecules typically consisting of 20 to 30 nucleotides, play crucial roles in antisense therapy, gene silencing, and as primers or probes in molecular biology. The manufacturing process involves sophisticated techniques including solid-phase synthesis using phosphoramidite chemistry, followed by deprotection, cleavage, purification (typically using reverse-phase HPLC), and rigorous quality control analysis to ensure high purity and correct sequence integrity. These precision molecules continue to underpin the advancement of nucleic acid therapeutics and personalized medicine approaches.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5182/oligonucleotide-process-development-and-manufacturing-market
According to a newly published market research report by 24LifeSciences, global oligonucleotide process development and manufacturing market was valued at USD 1.14 billion in 2024 and is projected to reach USD 2.04 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025-2031.
Oligonucleotides, which are short, single-stranded DNA or RNA molecules typically consisting of 20 to 30 nucleotides, play crucial roles in antisense therapy, gene silencing, and as primers or probes in molecular biology. The manufacturing process involves sophisticated techniques including solid-phase synthesis using phosphoramidite chemistry, followed by deprotection, cleavage, purification (typically using reverse-phase HPLC), and rigorous quality control analysis to ensure high purity and correct sequence integrity. These precision molecules continue to underpin the advancement of nucleic acid therapeutics and personalized medicine approaches.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5182/oligonucleotide-process-development-and-manufacturing-market
Oligonucleotide CDMO Market’s CAGR of 8.9%: Key Players According to a newly published market research report by 24LifeSciences, global oligonucleotide process development and manufacturing market was valued at USD 1.14 billion in 2024 and is projected to reach USD 2.04 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025-2031. Oligonucleotides, which are short, single-stranded DNA or RNA molecules typically consisting of 20 to 30 nucleotides, play crucial roles in antisense therapy, gene silencing, and as primers or probes in molecular biology. The manufacturing process involves sophisticated techniques including solid-phase synthesis using phosphoramidite chemistry, followed by deprotection, cleavage, purification (typically using reverse-phase HPLC), and rigorous quality control analysis to ensure high purity and correct sequence integrity. These precision molecules continue to underpin the advancement of nucleic acid therapeutics and personalized medicine approaches. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5182/oligonucleotide-process-development-and-manufacturing-market
0 Comments 0 Shares
